REICH SIEGFRIED (EVP & Chief Scientific Officer) sold 90.2% of their position (35.55K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.73M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+35.55K
Price / share
$51.28
Trade value
$1.82M
% of position
Common Stock
Shares
−3K
Price / share
$102.01
Trade value
$306.54K
% of position
Common Stock
Shares
−8.82K
Price / share
$102.87
Trade value
$907.31K
% of position
Common Stock
Shares
−6.22K
Price / share
$103.65
Trade value
$644.70K
% of position
Common Stock
Shares
−2K
Price / share
$104.97
Trade value
$209.94K
% of position
Common Stock
Shares
−3.10K
Price / share
$105.71
Trade value
$328.02K
% of position
Common Stock
Shares
−6.72K
Price / share
$107.13
Trade value
$719.49K
% of position
Common Stock
Shares
−3.68K
Price / share
$107.85
Trade value
$396.78K
% of position
Common Stock
Shares
−707.00
Price / share
$108.92
Trade value
$77.01K
% of position
Common Stock
Shares
−700.00
Price / share
$110.59
Trade value
$77.41K
% of position
Common Stock
Shares
−600.00
Price / share
$111.46
Trade value
$66.88K
% of position
Net shares
+0.00
Net value
-$1.91M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2021 | M · Option Exercise | +35.55K | $51.28 | $1.82M | 924.6% | 3.85K | 39.40K |
| Common Stock Direct | 3/4/2021 | S · Sale | −3K | $102.01 | $306.54K | 7.6% | 39.40K | 36.39K |
| Common Stock Direct | 3/4/2021 | S · Sale | −8.82K | $102.87 | $907.31K | 24.2% | 36.39K | 27.57K |
| Common Stock Direct | 3/4/2021 | S · Sale | −6.22K | $103.65 | $644.70K | 22.6% | 27.57K | 21.35K |
| Common Stock Direct | 3/4/2021 | S · Sale | −2K | $104.97 | $209.94K | 9.4% | 21.35K | 19.35K |
| Common Stock Direct | 3/4/2021 | S · Sale | −3.10K | $105.71 | $328.02K | 16.0% | 19.35K | 16.25K |
| Common Stock Direct | 3/4/2021 | S · Sale | −6.72K | $107.13 | $719.49K | 41.3% | 16.25K | 9.53K |
| Common Stock Direct | 3/4/2021 | S · Sale | −3.68K | $107.85 | $396.78K | 38.6% | 9.53K | 5.85K |
| Common Stock Direct | 3/4/2021 | S · Sale | −707.00 | $108.92 | $77.01K | 12.1% | 5.85K | 5.14K |
| Common Stock Direct | 3/4/2021 | S · Sale | −700.00 | $110.59 | $77.41K | 13.6% | 5.14K | 4.45K |
| Common Stock Direct | 3/4/2021 | S · Sale | −600.00 | $111.46 | $66.88K | 13.5% | 4.45K | 3.85K |
| Total | +0.00 | -$1.91M | ||||||
Stock Option (right to buy)
Common Stock
35.55K shares
Shares
−35.55K
Strike price
51.28
Held after
114.45K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock35.55K shares | 3/4/2021 | M · Option Exercise | −35.55K | 51.28 | — | 114.45K |